Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.31 |
| ▸ | MGMT | P16455 | 1/20 | 0.31 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4318852 | 0.95 | MAPT (0.47) | MAPK1MAPTATMTSHRGAA | |
| SCHEMBL23181 | 0.88 | MAPK1 (0.55) | MAPK1MAPTATMTSHRHSD17B10 | |
| Hydrogen Sulfide SCHEMBL20395887 | 0.85 | MAPK1 (0.53) | MAPK1MAPTATMTSHRHSD17B10 | |
| SCHEMBL10798317 | 0.81 | MAPK1 (0.50) | MAPK1MAPTHSD17B10CDK1CCNB1 | |
| SCHEMBL2114184 | 0.80 | MAPT (0.46) | MAPK1MAPTATMTSHRGAA | |
| SCHEMBL10456577 | 0.79 | MAPT (0.39) | MAPK1MAPTATMTSHRGAA | |
| SCHEMBL10804391 | 0.78 | MAPT (0.44) | MAPK1MAPT | |
| SCHEMBL4111687 | 0.77 | MAPK1 (0.47) | MAPK1MAPTTSHRGAAALDH1A1 | |
| SCHEMBL11132586 | 0.77 | MAPK1 (0.47) | MAPK1MAPTHSD17B10CDK1CCNB1 | |
| SCHEMBL21875991 | 0.77 | MAPK1 (0.47) | MAPK1MAPTHSD17B10CDK1CCNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117230555-A | Processing technology of high Wen Qingxing shielding wave-proof sleeve for aviation | 芜湖航飞科技股份有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-121758866-A | Impact-resistant plastic and preparation method thereof | 深圳市吉塑工程塑料有限公司 | 2026-03-31 | — | — | CN | disclosed |
| EP-2436677-B1 | PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE, PROCESS FOR PRODUCING CURED SEALING FOR ELECTRONIC MATERIALS, SEMICONDUCTORS AND SOLAR CELL MATERIALS, AND PROCESS FOR PRODUCING CURED COATING MATERIAL FOR COATING ELECTRIC WIRES | SHINRYO CORP (JP) | 2025-02-12 | — | — | EP | disclosed |
| CN-117230555-A | Processing technology of high Wen Qingxing shielding wave-proof sleeve for aviation | 芜湖航飞科技股份有限公司 | 2023-12-15 | — | — | CN | disclosed |
| EP-2436701-B2 | Method for storing triallyl isocyanurate | SHINRYO CORP (JP) | 2021-12-22 | — | — | EP | disclosed |
| US-8691984-B2 | Method of storing triallyl isocyanurate | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2014-04-08 | — | — | US | disclosed |
| US-8691984-B2 | Method of storing triallyl isocyanurate | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2014-04-08 | — | — | US | disclosed |
| EP-2436701-B1 | Method for storing triallyl isocyanurate | NIPPON KASEI CHEM (JP) | 2013-08-07 | — | — | EP | disclosed |
| EP-2436701-B1 | Method for storing triallyl isocyanurate | NIPPON KASEI CHEM (JP) | 2013-08-07 | — | — | EP | disclosed |
| US-8431697-B2 | Triallyl isocyanurate, triallyl cyanurate and process for producing triallyl isocyanurate | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | NIPPON CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | NIPPON CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | NIPPON CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20120095225-A1 | METHOD OF STORING TRIALLYL ISOCYANURATE | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| EP-0250024-B1 | UNSATURATED PEROXIDES AND THEIR USE AS CROSS-LINKING AGENTS FOR POLYMERS | AKZO N.V. (NL) | 1991-02-27 | — | — | EP | disclosed |
| US-4855428-A | Triazine peroxides | AKZO N.V. (NL) | 1989-08-08 | — | — | US | disclosed |
| EP-0250024-A1 | Unsaturated peroxides and their use as cross-linking agents for polymers | AKZO N.V. (NL) | 1987-12-23 | — | — | EP | disclosed |
| US-4284772-A | ULTRAVIOLET RADIATION STABILIZERS FOR POLYMERS | AKZONA INCORPORATED (US) | 1981-08-18 | — | — | US | disclosed |
| US-4204060-A | ANTIOXIDANTS, UV STABILIZERS | AKZONA INCORPORATED (US) | 1980-05-20 | — | — | US | disclosed |
| US-3948796-A | Triallyl cyanurate with high ringbound chlorine content | AMERICAN CYANAMID COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095225-A1 | METHOD OF STORING TRIALLYL ISOCYANURATE | TIMCC, TST, TMT1A | MAPK1 2473/4885MAPT 1336/4885ATM 236/4885 |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | CA9, CROCC, CA2 | MAPK1 2768/4885MAPT 3564/4885ATM 1245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.